Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rFVIIa prophylaxis in children with haemophilia A and inhibitors
2009-010172-21Phase 2Terminated
- Sponsor
- Elena Santagostino
- Start
- Jun 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of Coagulation factor VIIa recombinant human in hemophilia A, sponsored by Elena Santagostino. Primary endpoint: Clinical outcome at Month 18. Started Jun 2009; status: terminated.
02
Drugs
Coagulation factor VIIa recombinant human
03
Conditions
hemophilia A
Beyond the preview
Go deeper on 2009-010172-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010172-21.